BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 116791)

  • 21. Concurrent hydralazine administration prevents nitroglycerin-induced hemodynamic tolerance in experimental heart failure.
    Bauer JA; Fung HL
    Circulation; 1991 Jul; 84(1):35-9. PubMed ID: 1905595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic responses to continuous use of prazosin and hydralazine in patients with refractory heart failure.
    Elkayam U; Mathur M; Frishman W; LeJemtel T; Strom J; Sonnenblick EH
    Clin Pharmacol Ther; 1981 Jul; 30(1):23-30. PubMed ID: 7237894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of hydralazine on the development of tolerance to continuous nitroglycerin.
    Parker JD; Parker AB; Farrell B; Parker JO
    J Pharmacol Exp Ther; 1997 Feb; 280(2):866-75. PubMed ID: 9023301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of haemodynamic effects of oral hydralazine and prazosin hydrochloride in patients with chronic congestive heart failure.
    Chatterjee K; Ports TA; Arnold S; Brundage B; Parmley W
    Br Heart J; 1979 Dec; 42(6):657-63. PubMed ID: 534582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beneficial effects of dopamine combined with intravenous nitroglycerin on hemodynamics in patients with severe left ventricular failure.
    Loeb HS; Ostrenga JP; Gaul W; Witt J; Freeman G; Scanlon P; Gunnar RM
    Circulation; 1983 Oct; 68(4):813-20. PubMed ID: 6413087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrophysiologic properties of hydralazine in man.
    Gould L; Reddy CV; Zen B; Singh BK; Becker WH
    Pacing Clin Electrophysiol; 1980 Sep; 3(5):548-54. PubMed ID: 6160553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haemodynamic effects of nitroglycerin infusion in patients with postinfarction heart failure.
    Korewicki J; Kraska T; Ostrzycki A; Opolski G
    Cor Vasa; 1985; 27(4):251-8. PubMed ID: 3931975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preload and afterload without anguish: a simplified framework.
    Mandell HN; Deglin SM
    Postgrad Med; 1982 May; 71(5):105-12. PubMed ID: 6803231
    [No Abstract]   [Full Text] [Related]  

  • 29. [New aspects of the treatment of left ventricular failure: Nitroglycerin (author's transl)].
    Bussmann WD
    Med Klin; 1975 Oct; 70(42):1697-1706. PubMed ID: 810653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does the magnitude of mitral regurgitation determine hemodynamic response to vasodilation in chronic congestive heart failure?
    Haeusslein EA; Greenberg BH; Massie BM
    Chest; 1991 Nov; 100(5):1312-5. PubMed ID: 1935287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nitrates in heart failure. Pathophysiological mechanisms and therapeutic applications.
    Timmis AD; Richardson PJ
    Scand J Clin Lab Invest Suppl; 1984; 173():59-64. PubMed ID: 6442003
    [No Abstract]   [Full Text] [Related]  

  • 32. [Vasodilator therapy in cardiac failure].
    Akatsuka N
    Nihon Rinsho; 1993 May; 51(5):1276-80. PubMed ID: 8101237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variable hemodynamic response to oral hydralazine in patients with refractory congestive heart failure.
    LeJemtel TH; Elkayam U; Ribner HS; Hellman C; Strom J; Frishman W; Strobeck J; Sonnenblick EH
    Eur Heart J; 1980 Jun; 1(3):157-63. PubMed ID: 7026250
    [No Abstract]   [Full Text] [Related]  

  • 34. Oral hydralazine therapy for chronic refractory heart failure.
    Chatterjee K; Parmley WW; Massie B; Greenberg B; Werner J; Klausner S; Norman A
    Circulation; 1976 Dec; 54(6):879-83. PubMed ID: 825327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydralazine in the management of left ventricular failure.
    Fitchett DH; Neto JA; Oakley CM; Goodwin JF
    Am J Cardiol; 1979 Aug; 44(2):303-9. PubMed ID: 463768
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of intravenous nitroglycerin on hemodynamics of congestive heart failure.
    Pitt WA; Friedman RG; Gross SA; Glassman J; Keating EC; Mazur JH
    Angiology; 1982 May; 33(5):294-301. PubMed ID: 6805373
    [No Abstract]   [Full Text] [Related]  

  • 37. A randomized comparison between the hemodynamic effects of hydralazine and nitroglycerin alone and in combination at rest and during isometric exercise in patients with chronic mitral regurgitation.
    Roth A; Shotan A; Elkayam U
    Am Heart J; 1993 Jan; 125(1):155-63. PubMed ID: 8417512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodynamic effects of hydralazine in infants with idiopathic dilated cardiomyopathy and congestive heart failure.
    Artman M; Parrish MD; Appleton S; Boucek RJ; Graham TP
    Am Heart J; 1987 Jan; 113(1):144-50. PubMed ID: 3799428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasodilator treatment with isosorbide dinitrate and hydralazine in chronic heart failure.
    Massie BM; Kramer B; Shen E; Haughom F
    Br Heart J; 1981 Apr; 45(4):376-84. PubMed ID: 7225252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sublingual nitroglycerin in the treatment of left ventricular failure and pulmonary edema.
    Bussmann WD; Kaltenbach M
    Eur J Cardiol; 1976 Sep; 4(3):327-33. PubMed ID: 823029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.